Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension.

Biecker E.

ISRN Hepatol. 2013 Jul 22;2013:541836. doi: 10.1155/2013/541836. Review.

2.

Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis.

Triantos C, Kalafateli M.

World J Hepatol. 2014 Jun 27;6(6):363-9. doi: 10.4254/wjh.v6.i6.363. Review.

3.

Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management.

Biecker E.

World J Gastroenterol. 2013 Aug 21;19(31):5035-50. doi: 10.3748/wjg.v19.i31.5035. Review.

4.

Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis.

Kong DR, Ma C, Wang M, Wang JG, Chen C, Zhang L, Hao JH, Li P, Xu JM.

World J Gastroenterol. 2013 Jul 14;19(26):4228-33. doi: 10.3748/wjg.v19.i26.4228.

5.

Prevention and management of gastroesophageal varices in cirrhosis.

Chen YI, Ghali P.

Int J Hepatol. 2012;2012:750150. doi: 10.1155/2012/750150.

7.

NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension.

Fiorucci S, Antonelli E, Morelli O, Mencarelli A, Casini A, Mello T, Palazzetti B, Tallet D, del Soldato P, Morelli A.

Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8897-902.

9.

Liver disease.

Ryder SD, Williams R.

Postgrad Med J. 1994 Mar;70(821):162-84. Review. No abstract available.

Items per page

Supplemental Content

Support Center